Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts
Annalisa Mupo(Wellcome Sanger Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Magdalene J. Seiler, Penny Wright(Cambridge University Hospitals NHS Foundation Trust), Nicla Manes(Wellcome Sanger Institute), Ruben Bautista(Wellcome Sanger Institute), David G. Kent(University of York), Alena Pance(Wellcome Sanger Institute), Silvia Buonamici(New York University), Peter Campbell(Wellcome Sanger Institute), Yi‐Tsung Yang(Wellcome Sanger Institute), Niccolò Bolli(Wellcome Sanger Institute), Anant A. Agrawal, Vijitha Sathiaseelan(Wellcome/MRC Cambridge Stem Cell Institute), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Suruchi Pacharne(Wellcome Sanger Institute), Francesco Iorio(Open Targets), Konstantinos Tzelepis(The Gurdon Institute)
Cited by 124
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k